Do You Need a License to Sell Peptides in New York?

No state issues a document called a 'peptide license,' so the honest answer is that it depends on which of three separate regulatory questions your business actually triggers. Generally, selling anything in New York starts with ordinary business formation and tax registration. A second layer applies if what you distribute is treated as a drug or similar regulated product, which in most states pulls in wholesale distributor registration and separate federal obligations. The third layer — the one resellers underestimate most often — is the research-use-only lane, which is not a permit at all but an operating discipline covering labeling, marketing claims, and who you are permitted to sell to. Which layers apply to you is a fact question about your entity, your catalog, and your customers. Resolve it with an attorney licensed in New York and, where relevant, the state board that oversees pharmacy and distribution licensure. This article is informational, not legal advice.

Three questions hiding inside one

The first question is the boring one, and it is the same for a peptide catalog as it is for a candle company. Generally, a business operating in New York needs a legal entity registered with the state, a tax registration that lets it collect and remit sales tax where applicable, and whatever county or municipal filings its locality requires. None of that is peptide-specific. It is also the layer people mistake for a complete answer — forming an LLC and getting a resale certificate tells you nothing about whether the product itself is regulated.

The second question is product classification. This is where the answer stops being generic. In most states, distributing products that are legally treated as drugs requires registration as a wholesale distributor, and federal law adds its own layer on top of the state one. The critical point for a peptide business is that classification is not decided by the molecule alone. Regulators generally look at how a product is presented — its labeling, its packaging, the claims on the website, the questions your sales team answers. Two businesses can ship the identical vial and land in different regulatory categories because one described it as laboratory material and the other described it as something a person would use.

The third question is whether your operation genuinely stays inside research-use-only boundaries. Research-use-only is not a license you apply for and hang on the wall. It is a set of constraints you either honor consistently or violate quietly, and it is enforced through the same evidence a regulator would use to classify your product in the first place.

Why intended use, not the compound, drives the answer

Operators tend to ask which peptides are legal to sell. That framing rarely produces a useful answer, because the more consequential variable is intended use — what a reasonable observer would conclude your product is for, based on everything you publish about it. Your homepage copy is evidence. So are your product descriptions, your email sequences, your social captions, your packaging inserts, your customer service scripts, and the PDF someone on your team wrote and attached to an order confirmation.

This is why a catalog can be identical across two companies while their exposure is not. Dosing charts, administration instructions, before-and-after imagery, customer stories about how they felt, and any language describing a compound as something that treats or improves a condition all push a product toward being characterized as intended for human use. Once that characterization attaches, the question is no longer whether you need a general business license — it is whether you are distributing an unapproved drug, and that is a far more serious conversation.

The practical consequence is that compliance work in this category is mostly editorial and operational rather than clerical. Filing paperwork is easy. Governing what everyone in your organization says about the product, in writing, forever, is the hard part. Assign one person ownership of claim language. Review copy before it ships, not after a complaint arrives. Keep an archive of what your site said and when, because if a question ever comes up, reconstructing your own marketing history from memory is not a position you want to be in.

Questions to put to your attorney and the state board

Rather than trying to reason your way to a conclusion from articles like this one, bring a specific list to counsel. The value of a legal consultation collapses when the question is vague. These are the questions worth paying for:

• Given my exact catalog, labeling, and website copy, how is my product likely to be classified, and what changes would move that classification?
• Does my model require registration as a wholesale distributor in New York, and does it require registration in every state I ship into, or only where I hold inventory?
• Am I a distributor, a retailer, or a broker under the definitions that apply to me — and does drop-shipping change that answer?
• What supplier documentation must I collect and retain, and for how long?
• What customer qualification am I obligated to perform before accepting an order?
• Which advertising claims would, in your judgment, change my regulatory posture?
• What recordkeeping would I need to produce if a state agency asked tomorrow?

Ask your state board the licensure questions directly, in writing, and keep the response. Guidance you can point to later is worth more than a phone call you half remember. Never assume that registration in one state carries into another, and never assume a supplier's compliance posture transfers to you. It does not. Your obligations are yours.

What research-use-only actually requires of you

If you operate in the research-use-only lane, the constraints are concrete. Compounds are sold as laboratory materials, not for human or animal use. That means no dosing guidance, no administration instructions, no protocol documents, no efficacy promises, and no framing that describes what a person would experience. Where research findings are relevant to a buyer's understanding of a compound, they are described as what studies indicate or what research suggests about the molecule — never as an outcome you are offering.

It also means being deliberate about what you sell alongside what. Pairing compounds with injection supplies in a single bundle communicates an intended use regardless of what the disclaimer says. Regulators read the shopping cart, not just the footer.

Operationally, the lane requires customer qualification, clean labeling that matches your claims, storage and handling practices that protect product integrity, and retention of the certificate of analysis for every lot you receive. If a customer asks about a lot from months ago, you should be able to produce the paperwork in minutes. Train anyone who touches customer communication on where the line sits, because a single helpful reply from a support inbox can undo an otherwise careful compliance posture. Document that training. The point of documentation is not bureaucracy — it is that a pattern of consistent, provable practice is what distinguishes a business operating in good faith from one improvising.

How to vet a wholesale supplier before you commit

Your supplier's practices become part of your record. If a buyer or an agency ever asks what you sold and how you knew it was what you said it was, the answer is whatever your supplier can document. Vet accordingly.

Two patterns deserve specific suspicion. The first is testing you cannot verify — a purity figure printed on a page with no underlying document, or a COA that exists but is treated as a paid add-on. If the lab work is real, showing it costs nothing. The second is pricing that only appears after a sales call. Hidden pricing is not always a red flag on its own, but combined with unverifiable testing it usually indicates a supplier whose margin depends on the buyer not comparing carefully.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built for business buyers who have to answer for what they stock. Compounds are tested to 99%+ HPLC purity, and each batch is screened across a documented panel covering identity, purity, and contamination testing rather than a single purity figure.

Certificates of analysis are publicly verifiable — a prospective partner can check the lab results before applying, without a sales conversation and without paying for the document. That matters for a reason beyond marketing: it means the evidence supporting your catalog is evidence you can hand to a customer or produce for a file, not a claim you are repeating on faith.

Fulfillment originates in the United States, so orders move on a domestic schedule rather than through an unpredictable international transit and customs window; confirm current lead times when you order. The wholesale application itself is a three-step process — submit the application, get reviewed for account approval, and receive tier pricing and ordering access. Tier structure is disclosed rather than quote-gated. Catalog planning is straightforward as well, since collections such as the popular peptides range are browsable before you commit to an account.

Everything in the catalog is research use only. Real Peptides does not supply compounds outside that framing, and the program is not a substitute for your own licensure analysis.

Where this leaves a New York buyer

If you have confirmed your entity registration, had counsel review your classification, and built your operation to stay inside research-use-only boundaries, the remaining decision is supplier selection — and that decision should turn on verifiable testing, transparent pricing, and documentation you can actually produce. Businesses that meet those conditions can submit an application to the Wholesale Partner Program for review, at which point account approval and tier pricing follow.

For more on program structure and next steps, see the wholesale peptides program overview, the broader guidance on do you need a license to sell peptides, or apply for a wholesale account directly.